ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation

Laurent Yvan-Charvet1, Tamara Pagler, Emmanuel L Gautier

  • 1Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY 10032, USA. ly2159@columbia.edu

Science (New York, N.Y.)
|May 22, 2010
PubMed

Insights

Mice lacking ABCA1 and ABCG1 transporters showed increased white blood cells and stem cells, driving disease. Restoring high-density lipoprotein (HDL) levels reversed these effects, suggesting a link between cholesterol transport and blood cell proliferation.

Area of Science:

  • Cardiovascular Biology
  • Hematopoiesis
  • Atherosclerosis Research

Background:

  • Leukocytosis, particularly monocytosis, is linked to atherosclerosis.
  • The mechanisms driving elevated leukocyte counts remain unclear.
  • Adenosine triphosphate-binding cassette (ABC) transporters ABCA1 and ABCG1 are crucial for cholesterol efflux from macrophages and suppressing atherosclerosis.

Purpose of the Study:

  • To investigate the role of ABCA1 and ABCG1 in regulating hematopoietic stem and progenitor cell populations.
  • To understand the connection between ABC transporters, leukocytosis, and atherosclerosis development.

Main Methods:

  • Generation and analysis of mice deficient in ABCA1 and ABCG1.
  • Bone marrow transplantation experiments.
  • Assessment of hematopoietic stem and progenitor cell populations (LSK).
  • Evaluation of leukocytosis, myeloproliferative disorders, and atherosclerosis.

Main Results:

  • Mice lacking ABCA1 and ABCG1 exhibited leukocytosis, a myeloproliferative disorder, and expansion of Lin(-)Sca-1(+)Kit+ (LSK) stem and progenitor cells.
  • Transplantation of Abca1(-/-)Abcg1(-/-) bone marrow into high-density lipoprotein (HDL) transgenic mice suppressed LSK expansion and leukocytosis.
  • This transplantation also reversed the myeloproliferative disorder but accelerated atherosclerosis.

Conclusions:

  • ABCA1, ABCG1, and HDL play a critical inhibitory role in the proliferation of hematopoietic stem and multipotential progenitor cells.
  • Expansion of these stem and progenitor cell populations is directly linked to leukocytosis and accelerated atherosclerosis.
  • These findings establish a novel connection between cholesterol efflux pathways and the regulation of blood cell production in the context of atherosclerosis.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...